Bentham Science Logo

Current Drug Targets

Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Drug Targets, Volume 17 - Number 2




The Role of JNK Signalling in Responses to Oxidative DNA Damage

, 17(2): 154 - 163

Zeeshan Shaukat, Dawei Liu, Rashid Hussain, Mahwish Khan and Stephen L. Gregory


DOI: 10.2174/1389450116666150126111055



Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance

, 17(2): 164 - 177

Gabriela Nestal de Moraes, Laura Bella, Stefania Zona, Matthew J. Burton and Eric W.-F. Lam


DOI: 10.2174/1389450115666141122211549





Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions

, 17(2): 206 - 228

Rakesh Raj, Pooja Mongia, Suresh Kumar Sahu and Alpana Ram


DOI: 10.2174/1389450116666150722141607



The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease

, 17(2): 229 - 238

Alessandra Fierabracci, Andrea Del Fattore, Marta Muraca, Domenico Vittorio Delfino and Maurizio Muraca


DOI: 10.2174/1389450116666150722140633






Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.18

Related Journals

Related eBooks

eBooks Catalog